Antisense & RNAi Technology Market Research Reports & Industry Analysis
Antisense and RNAi technology has the potential to influence gene expression, offering new possibilities for treating previously challenging diseases. Staying informed about this evolving field is crucial, and MarketResearch.com's reports on the antisense and RNAi technology industry are valuable resources. These reports offer in-depth analyses of industry trends, challenges, and opportunities to help stakeholders make well-informed decisions based on accurate information.
Comprehensive Antisense and RNAi Technology Research
- Find research on a wide spectrum of key market segments including reagents, consumables, RNAi drug delivery, and RNAi therapeutics.
- Gain a holistic view of the industry by delving into RNAi market sizing, growth trajectories, technological breakthroughs, and competitor strategies.
- Understand the trends that are shaping the antisense and RNAi technology industry to stay ahead of the curve in an environment characterized by change.
Why Choose MarketResearch.com
Whether you're a busy executive or a professional in the field, our antisense and RNAi technology market research reports are designed to meet your information needs. These reports offer reliable data to support your business decisions and help you take advantage of emerging market opportunities. Embrace the value of knowledge and confidently explore the potential of the antisense and RNAi technology industry with MarketResearch.com.
Antisense & RNAi Technology Industry Research & Market Reports
-
The 2026-2031 World Outlook for Drug Discovery and Development RNA Interference (RNAi)
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2026-2031 World Outlook for RNA Interference (RNAi) Technologies
... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More
-
The 2026-2031 World Outlook for Antisense and RNAi Therapeutics
... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More
-
The 2026-2031 World Outlook for RNAi Therapeutics
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for RNAi Drug Deliveries
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
The 2026-2031 World Outlook for RNAi Therapies
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for RNAi Technologies
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
Antisense & RNAi Therapeutics Market Report by Technology (RNA Interference, Antisense RNA), Route of Administration (Intravenous Route, Subcutaneous Route, Intrathecal Route, Pulmonary Delivery, Intraperitoneal Injection, and Others), Application (Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Renal Diseases, Neurodegenerative Disorders, Genetic Disorders, Infectious Diseases, and Others), and Region 2025-2033
... during 2025-2033. The market is experiencing steady growth driven by the increasing prevalence of genetic and chronic diseases globally necessitates innovative treatments, supportive regulatory environments across major markets to expedite the approval and commercialization of ... Read More
-
RNA Interference (RNAi)
... at a CAGR of 10.0% over the analysis period 2024-2030. Drug Discovery & Development, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$118.1 Billion by the ... Read More
-
Antisense and RNAi Therapeutics
... 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. Antisense RNA, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$1.8 Billion by the ... Read More
-
Innovative Medicine Market, By Therapy Type (Immunotherapy, Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecule Therapy, Biologic Therapy, RNA-Based Therapy, Progenitor Cell Therapy, Peptide-Based Therapy, Microbiome Therapy, Antisense Oligonucleotide Therapy, CRISPR-based Therapy, mRNA-based Vaccines, and Monoclonal Antibodies), By Application (Oncology, Neurology, Cardiology, Ophthalmology, Dermatology, Musculoskeletal Disorders, Immunology & Inflammation, Genetic Disorders, Infectious Diseases, Metabolic Disorders, Hematology, Rare Diseases, Gastroenterology, and Others), By Route of Administration (Oral, Intravenous, Subcutaneous, Intramuscular, Topical, and Inhalation), By End User (Hospitals & Clinics, Academic & Research Institutes, Specialty Centers, Ambulatory Surgical Centers, Government & Regulatory Bodies, and Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
... Innovative medicines, also known as specialty drugs or biopharmaceuticals, are advanced medical treatments that offer new and improved therapeutic options for various diseases. These medicines are developed using cutting-edge technologies and are designed to target ... Read More
-
Rnai Technology Market, By Application (Drug Discovery and Development, Therapeutics, Functional Genomics, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs & CMOs, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... (siRNAs) or microRNAs (miRNAs). It has emerged as a powerful tool for selective inhibition of gene expression and functional genomics screens. RNAi holds immense potential for developing novel therapeutics by silencing specific disease-causing genes. The ... Read More
-
2025 Global Forecast for Mirna Tools And Services Market (2026-2031 Outlook)-High Tech Outlook Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Treatment Market, By Type (Hereditary Transthyretin Amyloidosis (hATTR), Wild Type Transthyretin Amyloidosis (wtATTR)), By Drug Type (Transthyretin Stabilizers, Nonsteroidal Anti-Inflammatory Drugs (NSAID), RNAi Therapy, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... shortness of breath and peripheral edema, and other symptoms related to buildup of amyloid fibrils in the body. There are two forms of transthyretin amyloid cardiomyopathy (ATTR-CM); hereditary transthyretin amyloidosis (hATTR) and wild type transthyretin ... Read More
-
Antisense & RNAi Therapeutics Global Market Report 2025
... rnai therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Genome Editing/Genome Engineering Global Market Report 2025 Including: 1) By Product And Service: Reagents And Consumables; Software And systems; Services 2) By Technology: CRISPR; TALEN; ZFN; Antisense 3) By Application: Cell Line Engineering; Genetic Engineering; Diagnostic Applications; Drug Discovery And Development 4) By End User: Biotechnology Companies; Pharmaceutical Companies; Academic And Government Research Institutes Covering: Thermo Fisher Scientific Inc.; Merck Group; Genscript Biotech Corp; Sangamo Therapeutics Inc.; Lonza Group AG
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Antisense Oligonucleotides Market- Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032
... from 2024 to 2032. The market is experiencing significant growth due to several key factors. The increasing prevalence of genetic diseases, such as Duchenne muscular dystrophy (DMD) and spinal muscular atrophy (SMA), has amplified the ... Read More
-
RNA Interference (RNAi) Drug Delivery Market Report by Application (Infectious Disease, Cardiology, Oncology, Neurology, Ophthalmology, Urology, Metabolic Disorders, and Others), Technology (Nanoparticle Drug Delivery, Pulmonary Drug Delivery, Nucleic Acid Drug Delivery, Aptamer Drug Delivery), and Region 2025-2033
... 17.75% during 2025-2033. Ribonucleic acid interference (RNAi) drug delivery refers to a therapeutic solution to monitor gene expression or mutations. RNAi drug delivery is usually administered through intravenous, intra-dermal and intraperitoneal injections and topical delivery ... Read More
-
Gene Editing Market Assessment, By Products and Services [Reagents and Consumables, Software and Systems, Services], By Technique [Knock-in, Knock-out, Gene Silencing, Others], By Method [Ex-vivo, In-vivo], By Technology [CRISPR, TALENs, ZFN, Antisense, Others], By Application [Genetic Engineering, Clinical Applications], By End-user [Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, CROs and CDMOs], By Region, Opportunities and Forecast, 2018-2032F
... by the rising applications of gene editing in various industries, the increasing prevalence of chronic disorders, the growing requirement for personalized medicines, and rising research and development activities. Additionally, the rising adoption of gene editing ... Read More
-
Global Viral Vectors And Plasmid DNA Manufacturing Market By Vector Type (Adenovirus, Retrovirus, Adeno-Associated Virus (AAV), Lentivirus, Plasmids, Others), By Applications (Antisense & RNAi Therapy, Gene Therapy, Cell Therapy, Vaccinology, Research Applications), By Disease (Cancer, Genetic Disorders, Infectious Diseases, Others), By End-Use (Pharmaceutical and Biopharmaceutical Companies, Research Institutes) By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Industry Trends and Forecast to 2030.
... Genetic Disorders, Infectious Diseases, Others), By End-Use (Pharmaceutical and Biopharmaceutical Companies, Research Institutes) By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Industry Trends and Forecast to 2030. Global Viral ... Read More
-
2025 Global Forecast for Antisense And Rnai Therapeutics Market (2026-2031 Outlook)-High Tech Outlook Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
2025 Global: Antisense And Rnai Therapeutics Market - Innovative Markets Forecast (2031) report
... accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only ... Read More
-
Global RNA Interference (RNAi) Drug Delivery Market Growth 2024-2030
... demand in downstream market, the RNA Interference (RNAi) Drug Delivery is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More
-
RNA Interference (RNAi) Pesticides Market Forecasts to 2030 – Global Analysis By Type (Synthetic RNAi Pesticides and Natural RNAi Pesticides), Mode of Action (Gene Silencing and RNA Interference), Crop Type, Application, End User and By Geography
... Geography According to Stratistics MRC, the Global RNA Interference (RNAi) Pesticides Market is accounted for $1.40 billion in 2024 and is expected to reach $2.75 billion by 2030 growing at a CAGR of 11.92% during ... Read More
-
Global Antisense & RNAi Therapeutics Market Growth (Status and Outlook) 2024-2030
... With growing demand in downstream market, the Antisense & RNAi Therapeutics is forecast to a readjusted size of US$ 1268.5 million by 2030 with a CAGR of 4.4% during review period. The research report highlights ... Read More
Research Assistance
